NeuroOne Medical Technologies Corporation

Investors have three direct lines to @N1MTC. Our investor relations channels on @Stocktwits, @YahooFinance, and @X share company updates, milestones, and news as it happens. Follow us here: @YahooFinance: NeuroOne_IR @X: @NeuroOne_IR @Stocktwits: NeuroOne_IR

@N1MTC is part of a @dartmouth-led research team awarded NIH funding through the BRAIN Initiative. The project will combine neurochemical sensing with our sEEG electrode technology. Full announcement: lnkd.in/gK4tgqxM

Precision over systemic exposure. Dr. Sandipan Pati of the @UMNews on the case for targeted brain drug delivery — the goal behind @N1MTC's work in this space.

Trigeminal neuralgia is one of the most debilitating pain conditions that patients face. The OneRF® Trigeminal Nerve Ablation System gives surgeons a precise, minimally invasive option to treat facial pain. Learn more: nmtc1.com/trigeminal-neuralg… (Caution: RxOnly)

@n1mtc has received ISO 13485:2016 certification, the international quality management standard for medical devices, achieved ahead of schedule. Full release here: ir.nmtc1.com/press-release-d… (Caution: RxOnly)

@N1MTC has launched official investor relations channels on @Stocktwits, @YahooFinance, and @X to establish a dedicated space for transparent updates and open dialogue with our investor community. Yahoo Finance: @NeuroOne_IR X: @NeuroOne_IR Stocktwits: @NeuroOne_IR

@N1MTC's pipeline reflects our commitment to expanding treatment options for patients with neurological disorders. Take a closer look at what we are building next. nmtc1.com/products-in-develo…

@N1MTC is excited to launch our new Products in Development page on our website. Get a peek into the technologies of the future that we hope will redefine treatments and patient care. nmtc1.com/products-in-develo…

Our work is driven by the patients we serve. nmtc1.com

"We call it brain, pain, and drug delivery." — @N1MTC CEO Dave Rosa In case you missed it, Dave joined @adamsarhan of Smart Money Circle to talk about the technology behind those three words — and what's ahead for NeuroOne. open.spotify.com/episode/68n…

@N1MTC CEO Dave Rosa joined @adamsarhan of Smart Money Circle Show to talk about what NeuroOne is building — and why it matters for patients with epilepsy, trigeminal neuralgia, and chronic pain.  (Caution: RxOnly) youtube.com/watch?v=M-ZXv0S9…

Congratulations to our team member Aura Kullmann for presenting her research at the American Association of Neurological Surgeons (AANS) 2026 Annual Meeting! Thank you, Aura, for representing @N1MTC at AANS and advancing the science behind our platform. (Caution: RxOnly)

@N1MTC is excited to present at the American Society of Gene & Cell Therapy 2026 Annual Meeting, May 11-15 in Boston, MA. Join us at booth 1400 to learn about our sEEG-Drug Delivery System (CED with Neural Recording & Stimulation Capability).

@N1MTC is proud to highlight the scientific and clinical posters related to the OneRF® Ablation System and other NeuroOne products in development. These will be presented at the American Association of Neurological Surgeons (AANS) 2026 Annual Meeting. (Caution: RxOnly)

@N1MTC is excited to present at the American Association of Neurological Surgeons (AANS) 2026 Annual Meeting — May 1–4 at the Henry B. González Convention Center in San Antonio, Texas. We'll be there alongside our strategic partner @zimmerbiomet. (Caution: RxOnly)

Our commitment to advancing epilepsy care drives everything we do. nmtc1.com

Parkinson's disease affects tens of thousands each year—impacting patients, families, and healthcare systems. At @N1MTC, we're transforming neurological care through minimally invasive technologies. Awareness is the first step. Innovation drives the rest.

Advancing epilepsy care starts with precision. Our Evo® sEEG electrodes provide high-definition recording of brain activity for patients undergoing epilepsy evaluation. Precise seizure localization is critical for determining the best treatment path. (Caution: RxOnly)